Logo image of SGMA

SIGMATRON INTERNATIONAL INC (SGMA) Stock Fundamental Analysis

NASDAQ:SGMA - Nasdaq - US82661L1017 - Common Stock - Currency: USD

1.45  -0.01 (-0.68%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to SGMA. SGMA was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. SGMA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SGMA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year SGMA has reported negative net income.
SGMA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: SGMA reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: SGMA reported negative operating cash flow in multiple years.
SGMA Yearly Net Income VS EBIT VS OCF VS FCFSGMA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

SGMA has a Return On Assets of -7.59%. This is in the lower half of the industry: SGMA underperforms 65.00% of its industry peers.
The Return On Equity of SGMA (-29.06%) is worse than 72.50% of its industry peers.
SGMA has a Return On Invested Capital (1.96%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SGMA is above the industry average of 8.95%.
The 3 year average ROIC (11.58%) for SGMA is well above the current ROIC(1.96%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -7.59%
ROE -29.06%
ROIC 1.96%
ROA(3y)-1.8%
ROA(5y)-0.88%
ROE(3y)-7.6%
ROE(5y)-3.93%
ROIC(3y)11.58%
ROIC(5y)7.9%
SGMA Yearly ROA, ROE, ROICSGMA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

SGMA's Operating Margin of 0.47% is in line compared to the rest of the industry. SGMA outperforms 48.33% of its industry peers.
SGMA's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 8.17%, SGMA is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of SGMA has remained more or less at the same level.
Industry RankSector Rank
OM 0.47%
PM (TTM) N/A
GM 8.17%
OM growth 3Y15.94%
OM growth 5Y12.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.13%
GM growth 5Y-0.18%
SGMA Yearly Profit, Operating, Gross MarginsSGMA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

4

2. Health

2.1 Basic Checks

SGMA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for SGMA has been increased compared to 1 year ago.
SGMA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SGMA has been reduced compared to a year ago.
SGMA Yearly Shares OutstandingSGMA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
SGMA Yearly Total Debt VS Total AssetsSGMA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 1.91 indicates that SGMA is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of SGMA (1.91) is worse than 67.50% of its industry peers.
SGMA has a debt to FCF ratio of 2.92. This is a good value and a sign of high solvency as SGMA would need 2.92 years to pay back of all of its debts.
The Debt to FCF ratio of SGMA (2.92) is better than 67.50% of its industry peers.
SGMA has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
SGMA has a Debt to Equity ratio (0.09) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 2.92
Altman-Z 1.91
ROIC/WACC0.19
WACC10.33%
SGMA Yearly LT Debt VS Equity VS FCFSGMA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

SGMA has a Current Ratio of 1.16. This is a normal value and indicates that SGMA is financially healthy and should not expect problems in meeting its short term obligations.
SGMA has a worse Current ratio (1.16) than 90.83% of its industry peers.
SGMA has a Quick Ratio of 1.16. This is a bad value and indicates that SGMA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.32, SGMA is not doing good in the industry: 96.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 0.32
SGMA Yearly Current Assets VS Current LiabilitesSGMA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 31.64% over the past year.
The Revenue for SGMA has decreased by -15.22% in the past year. This is quite bad
The Revenue has been growing slightly by 5.17% on average over the past years.
EPS 1Y (TTM)31.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33951.64%
Revenue 1Y (TTM)-15.22%
Revenue growth 3Y10.42%
Revenue growth 5Y5.17%
Sales Q2Q%-24.29%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SGMA Yearly Revenue VS EstimatesSGMA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
SGMA Yearly EPS VS EstimatesSGMA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

2

4. Valuation

4.1 Price/Earnings Ratio

SGMA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SGMA Price Earnings VS Forward Price EarningsSGMA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

84.17% of the companies in the same industry are more expensive than SGMA, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, SGMA is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.39
EV/EBITDA 9.35
SGMA Per share dataSGMA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

SGMA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SIGMATRON INTERNATIONAL INC

NASDAQ:SGMA (2/21/2025, 8:00:02 PM)

1.45

-0.01 (-0.68%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)12-06 2024-12-06/bmo
Earnings (Next)03-06 2025-03-06
Inst Owners18.53%
Inst Owner Change18.53%
Ins Owners18.85%
Ins Owner Change0%
Market Cap8.87M
Analysts0
Price TargetN/A
Short Float %0.12%
Short Ratio0.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF 0.39
P/OCF 0.36
P/B 0.17
P/tB 0.17
EV/EBITDA 9.35
EPS(TTM)-2.54
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)3.73
FCFY257.19%
OCF(TTM)4.07
OCFY280.88%
SpS54.99
BVpS8.73
TBVpS8.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.59%
ROE -29.06%
ROCE 2.37%
ROIC 1.96%
ROICexc 2.08%
ROICexgc 2.11%
OM 0.47%
PM (TTM) N/A
GM 8.17%
FCFM 6.78%
ROA(3y)-1.8%
ROA(5y)-0.88%
ROE(3y)-7.6%
ROE(5y)-3.93%
ROIC(3y)11.58%
ROIC(5y)7.9%
ROICexc(3y)11.76%
ROICexc(5y)8.06%
ROICexgc(3y)12.49%
ROICexgc(5y)8.51%
ROCE(3y)14.02%
ROCE(5y)9.57%
ROICexcg growth 3Y42.8%
ROICexcg growth 5Y25.85%
ROICexc growth 3Y43.09%
ROICexc growth 5Y26.17%
OM growth 3Y15.94%
OM growth 5Y12.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.13%
GM growth 5Y-0.18%
F-Score5
Asset Turnover1.64
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 2.92
Debt/EBITDA 0.62
Cap/Depr 34.48%
Cap/Sales 0.62%
Interest Coverage 0.16
Cash Conversion 325.29%
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 0.32
Altman-Z 1.91
F-Score5
WACC10.33%
ROIC/WACC0.19
Cap/Depr(3y)59.02%
Cap/Depr(5y)70.3%
Cap/Sales(3y)0.93%
Cap/Sales(5y)1.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33951.64%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.22%
Revenue growth 3Y10.42%
Revenue growth 5Y5.17%
Sales Q2Q%-24.29%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-93.47%
EBIT growth 3Y28.02%
EBIT growth 5Y18.14%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y164.65%
FCF growth 3Y97.89%
FCF growth 5YN/A
OCF growth 1Y174.63%
OCF growth 3Y50.77%
OCF growth 5YN/A